![]() |
市場調查報告書
商品編碼
1913342
異丙醇市場機會、成長要素、產業趨勢分析及2026年至2035年預測Isopropyl Alcohol Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球異丙醇市場預計到 2025 年將達到 73 億美元,到 2035 年將達到 137 億美元,年複合成長率為 6.4%。

全球衛生標準的日益重視、藥品產能的不斷擴大以及技術主導行業對精密級清潔解決方案的日益成長的需求,共同支撐了市場成長。異丙醇因其消毒能力和作為藥品生產中可靠溶劑的作用而備受青睞。長期以來,人們對衛生和感染預防意識的不斷提高,使得市場需求遠超以往的激增,鞏固了其在多個行業中作為關鍵化學品的地位。同時,監管壓力和環境優先事項正在加速向生物基生產途徑和更環保的溶劑體系轉型。對永續化學品製造和供應鏈最佳化的投資正在重塑生產模式,使供應商能夠在提升環境績效的同時,專注於特種和高純度應用。這些結構性發展將持續增強市場的韌性和長期成長潛力。
| 市場覆蓋範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測年份 | 2026-2035 |
| 起始值 | 73億美元 |
| 預測金額 | 137億美元 |
| 複合年成長率 | 6.4% |
2025年,工業級異丙醇市佔率達到46.9%,預計到2035年將以6.4%的複合年成長率成長。其市場主導地位主要得益於其成本效益和廣泛的功能應用。較低的提純要求降低了生產能耗,並使其價格更具競爭力,從而支持工業運作中的大規模應用。
預計到 2025 年,醫療和製藥領域將佔市場佔有率的 34.1%,並預計從 2026 年到 2035 年以 6.5% 的複合年成長率成長。消毒劑在消毒和滅菌應用中的重要作用以及作為藥用級溶劑的應用,正在推動強勁的需求。
到 2025 年,北美異丙醇市佔率將達到 24.3%。該地區的成長得益於醫療保健、化學品製造和專業清潔行業的消費量增加,以及強大的工業基礎設施和一致的法規結構的支持。
The Global Isopropyl Alcohol Market was valued at USD 7.3 billion in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 13.7 billion by 2035.

Market growth is supported by rising global emphasis on hygiene standards, expanding pharmaceutical production capacity, and increasing use of precision-grade cleaning solutions across technology-driven industries. Isopropyl alcohol remains widely valued for its disinfecting capability and its role as a reliable solvent in pharmaceutical manufacturing. Heightened long-term awareness around sanitation and infection prevention has sustained demand well beyond earlier surges, reinforcing its position as an essential chemical across multiple industries. In parallel, regulatory pressure and environmental priorities are accelerating the shift toward bio-based production pathways and greener solvent systems. Investments in sustainable chemical manufacturing and supply chain optimization are reshaping production models, enabling suppliers to target specialty and high-purity applications while improving environmental performance. These structural developments continue to enhance market resilience and long-term growth potential.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $7.3 Billion |
| Forecast Value | $13.7 Billion |
| CAGR | 6.4% |
The industrial-grade isopropyl alcohol segment held 46.9% share in 2025 and is expected to grow at a CAGR of 6.4% through 2035. Its dominance is driven by cost efficiency and broad functional applicability. Lower purification requirements reduce production energy intensity, allowing competitive pricing and supporting large-scale usage across industrial operations.
The healthcare and pharmaceutical segment held 34.1% share in 2025 and is forecast to expand at a CAGR of 6.5% from 2026 to 2035. Strong demand is supported by the critical role of isopropyl alcohol in sanitation, antiseptic use, and pharmaceutical-grade solvent applications.
North America Isopropyl Alcohol Market represented 24.3% share in 2025. Regional growth is driven by rising consumption across healthcare, chemical manufacturing, and professional cleaning sectors, supported by strong industrial infrastructure and consistent regulatory frameworks.
Key companies operating in the Global Isopropyl Alcohol Market include Dow, LyondellBasell, SABIC, Shell Chemicals, LG Chem, Mitsubishi Chemical Group, ExxonMobil, INEOS, Solvay, Sasol, PetroChina, Mitsui Chemicals, Deepak Fertilisers and Petrochemicals Corporation Ltd., Tokuyama Corporation, ISU Chemical, SK Geo Centric, LCY, Kukdo Chemical, Jiangsu Denoir Specialty Chemicals, and Shandong Dadi Supu Chemical Co., Ltd.
Companies in the isopropyl alcohol market are strengthening their competitive position through capacity expansion, sustainability-focused innovation, and portfolio optimization. Many producers are investing in bio-based and low-emission production technologies to meet regulatory and customer expectations. Strategic geographic expansion and localized manufacturing are helping reduce supply risks and improve responsiveness. Firms are also emphasizing high-purity and specialty-grade offerings to capture value-added segments. Long-term supply agreements with pharmaceutical and industrial customers are being used to stabilize demand, while operational efficiency initiatives and digitalized production systems support cost competitiveness and consistent product quality.